Product image of Noresmea (Norethisterone Acetate, Estradiol) supplied by GNH India

Noresmea

Active Ingredient:
Norethisterone Acetate, Estradiol
Origin:
EU

Noresmea (Norethisterone Acetate, Estradiol)

Norethisterone acetate and estradiol, the active ingredients in Noresmea, are an estrogen‑progestogen combination presented as a 2 mg estradiol / 1 mg norethisterone acetate tablet for oral use. It relieves menopausal vasomotor symptoms, prevents osteoporosis and treats estrogen deficiency in post‑menopausal women.

GNH India supplies Noresmea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under a prescription‑only status.

Manufacturer / TM Owner

Sandoz A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Noresmea, an estrogen‑progestogen combination, is used in hormone replacement therapy for menopausal and estrogen‑deficiency conditions.

  • Menopausal vasomotor symptoms: reduces hot flashes, night sweats and related discomfort.
  • Osteoporosis prevention in post‑menopausal women: helps maintain bone mineral density and reduces fracture risk.
  • Estrogen deficiency syndrome: alleviates vaginal dryness, mood changes and other deficiency‑related symptoms.

How It Works

  • Noresmea delivers estradiol, which binds to estrogen receptors (ERα and ERβ) to restore estrogenic activity, and norethisterone acetate, a progestogen that activates progesterone receptors, providing progestogenic support. The combined action suppresses endometrial proliferation, stabilises hypothalamic thermoregulatory centers to reduce vasomotor symptoms, and supports bone remodeling, thereby addressing the physiological deficits of menopause.

Side Effects

Adverse reactions may occur with any hormone therapy. The following lists reported events.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Breast tenderness: transient swelling or discomfort.
  • Headache: occasional tension‑type headaches.
  • Bloating: abdominal distension or fluid retention.
  • Mood changes: irritability or mild depressive symptoms.
  • Weight gain: modest increase in body weight.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
  • Stroke: cerebrovascular accident, particularly in high‑risk patients.
  • Myocardial infarction: heart attack risk may increase.
  • Liver dysfunction: abnormal liver enzymes or hepatitis.
  • Severe allergic reaction: anaphylaxis, rash, or angioedema.
  • Endometrial cancer: risk if progestogenic protection is inadequate.

Precautions & Warnings

Before initiating Noresmea, clinicians should consider several safety aspects.

  • Cardiovascular assessment: evaluate history of thromboembolic events or cardiovascular disease.
  • Liver function: monitor hepatic enzymes in patients with liver impairment.
  • Bone health: assess baseline bone mineral density when used for osteoporosis prevention.
  • Breast health: perform regular examinations and imaging as indicated.
  • Pregnancy contraindication: avoid use in pregnant women; discontinue if pregnancy occurs.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Noresmea can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Combined estrogen therapy: additive risk of thromboembolism.
  • Anticoagulants (e.g., warfarin): may alter anticoagulant effect.
  • Strong CYP3A4 inducers (e.g., rifampicin): reduce hormone plasma levels.

Moderate Interactions (Monitor Closely)

  • SSRIs/SNRIs: may diminish hot‑flash relief.
  • Antihypertensives: possible fluid retention influencing blood pressure.
  • Thyroid hormone replacement: may affect hormone binding and dosage requirements.

Frequently Asked Questions

Noresmea is prescribed as hormone replacement therapy to relieve menopausal vasomotor symptoms such as hot flashes, to prevent osteoporosis in post‑menopausal women, and to treat estrogen deficiency syndrome by providing both estrogen and progestogen activity.

Estradiol in Noresmea binds to estrogen receptors, restoring estrogenic effects that regulate temperature control and bone metabolism. Norethisterone acetate activates progesterone receptors, offering progestogenic protection to the endometrium and complementing estrogen’s actions, together achieving balanced hormone replacement.

The specific dose and dosing schedule of Noresmea are determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Noresmea is contraindicated in pregnancy because the hormonal components can affect fetal development. It is also not recommended for breastfeeding women, as hormones may pass into breast milk and influence the infant. Women of child‑bearing potential should use effective contraception while on therapy.

To order Noresmea, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and import documentation.

Noresmea combines estradiol with norethisterone acetate in a single tablet, offering both estrogen and progestogen in a fixed ratio. Compared with separate estrogen‑only or progestogen‑only products, this combination simplifies dosing and ensures endometrial protection, but the safety profile and risk considerations remain similar to other combined HRT regimens.

Noresmea tablets should be stored at temperatures below 25 °C, in their original blister pack, protected from moisture and direct sunlight. Keep the medication out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Noresmea is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed to maintain proper absorption.

The most serious risks include venous thromboembolism, stroke, myocardial infarction, severe liver dysfunction, and rare cases of endometrial cancer if progestogenic protection is insufficient. Patients should be monitored for signs of clotting, cardiovascular events, and liver abnormalities throughout therapy.

Noresmea should not be used by women who are pregnant, have known or suspected breast or estrogen‑dependent cancers, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or any condition where combined estrogen‑progestogen therapy is contraindicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Norethisterone Acetate, Estradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT